Company profile: Shire
1.1 - Company Overview
Company description
- Provider of biotechnology products focused on serving people with rare diseases, supported by a global sales and marketing infrastructure. Offers a broad portfolio with direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy, and Spain.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Shire
Mavu Pharma
HQ: United States
Website
- Description: Provider of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mavu Pharma company profile →
Verseon
HQ: United States
Website
- Description: Provider of an AI- and quantum physics–based drug discovery platform that explores billions of chemical options to identify novel leads; clinical candidate development advancing multiple synthesized and characterized candidates with unique therapeutic profiles; and AI-enabled patient recruitment and trial conduct using a proprietary network for more efficient studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verseon company profile →
FibroGen
HQ: United States
Website
- Description: Provider of novel therapeutics leveraging CTGF and HIF biology, including Roxadustat, an oral small molecule for anemia in CKD patients on or off dialysis; Pamrevlumab, a human monoclonal antibody in development for metastatic and locally advanced pancreatic cancer and DMD; and FG-3246, a first-in-class fully human ADC targeting CD46 for metastatic castration-resistant prostate cancer and other tumors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FibroGen company profile →
Endo
HQ: Ireland
Website
- Description: Provider of branded and generic pharmaceuticals for patient care, offering affordable, high-quality generics and treatments for unmet pelvic health needs; supplies products tailored to Canadian and emerging markets, and engages in public policy advocacy to enhance patient access, alongside a UK tax strategy focused on compliance and responsible planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endo company profile →
Oxford Pharmascience
HQ: United Kingdom
Website
- Description: Provider of proprietary technology platforms to re-develop existing medicines to make them better, safer or easier to take, licensing its technologies and dossiers to a network of partners rather than manufacturing or selling directly to consumers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Pharmascience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Shire
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Shire
2.2 - Growth funds investing in similar companies to Shire
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Shire
4.2 - Public trading comparable groups for Shire
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →